1 Min Read
Sept 4(Reuters) - Taho Pharmaceuticals Ltd :
* Says it received patent for oral solution comprising atomoxetine hydrochloride and methods thereof in US
Source text in Chinese: goo.gl/XpmC9e
Further company coverage: (Beijing Headline News)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.